THCV236

THCV236 isn’t a standard term in cannabinoid science; it’s likely a catalog or batch code. Here’s a concise intro to THCV (tetrahydrocannabivarin).
- What it is: THCV is a cannabinoid found in cannabis, structurally similar to THC but with a propyl (three-carbon) side chain. It often occurs in smaller amounts than THC and can have a distinct pharmacological profile.
- Pharmacology: THCV interacts with the endocannabinoid system, notably CB1 and CB2 receptors. At low doses it can block or dampen CB1 activation (anti-THC-like effects); at higher doses it may act as a partial CB1 agonist. Its psychoactive effects are typically milder and different from THC.
- Potential effects and uses: research suggests THCV may influence appetite and metabolism (potential weight management/antidiabetic effects), anticonvulsant and neuroprotective properties, and anti-inflammatory activity. Human data are limited.
- Status: not approved as a medicine in most jurisdictions; most evidence comes from preclinical studies and early human trials.
- Clarification: if you meant a specific product, patent, or study labeled “THCV236,” please provide context for a targeted intro.

SOT-23 (3-pin) surface-mount package.

- Pharmacology and SAR: THCV236 CB1/CB2 binding and signaling profiling.
- Metabolic research: appetite suppression, energy balance, obesity/diabetes studies.
- Neuroprotective/anti-inflammatory and analgesic potential.
- Neurological/psychiatric research: anticonvulsant and related applications.
- Drug discovery tool: ligand screening and receptor profiling for cannabinoids.
- Analytical science: reference material and assay development for cannabinoid formulations.